Deutsche Bank lowered the firm’s price target on Pediatrix Medical (MD) to $19 from $21 and keeps a Hold rating on the shares. The firm says the company’s volumes were weaker than expected in Q4.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD:
- Pediatrix Medical Earnings Call Highlights Steady Margin Focus
- Pediatrix Medical price target lowered to $21 from $24 at Truist
- Pediatrix Medical Group: Streamlined Portfolio, Improved Payer Mix, and Margin Expansion Support Buy Rating Despite Volume Headwinds
- Pediatrix Medical reports Q4 adjusted EPS 50c, consensus 54c
- Pediatrix Medical sees FY26 adjusted EBITDA $280M-$300M